Welcome to our dedicated page for Transphorm news (Ticker: TGAN), a resource for investors and traders seeking the latest updates and insights on Transphorm stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Transphorm's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Transphorm's position in the market.
Transphorm, Inc. (Nasdaq: TGAN) has introduced a new 240W Power Adapter Reference Design, the TDAIO-TPH-ON-240W-RD, boasting over 96% peak efficiency and a power density of up to 30 W/in³. Utilizing three SuperGaN® FETs with low on-resistance, this design targets high-power applications like chargers and medical power supplies. The product joins a suite of adapter design tools, enhancing Transphorm's capacity in the power electronics market.
Transphorm, Inc. (NASDAQ: TGAN) has announced high reliability ratings for its Gallium Nitride (GaN) power FET devices, achieving an industry-leading 0.1 Failures in Time (FIT) rate after over 85 billion operational hours. This rating highlights the company's commitment to reliability in power conversion applications. The devices are categorized into low power (≤ 500 W) and high power ( 500 W), with FIT rates of 0.06 and 0.19 respectively. Transphorm continues to position itself as a leader in high voltage GaN technology across various markets including data centers and renewable energy.
Transphorm, Inc. (NASDAQ: TGAN), a leader in gallium nitride (GaN) power conversion products, announced that President & COO Primit Parikh, Ph.D., will present at the Oppenheimer 5G Summit: The Revolution Continues on December 13, 2022. The event will include a live fireside chat at 9:55 a.m. ET, with opportunities for investors to connect throughout the day. Transphorm is known for its high reliability and performance GaN semiconductors, boasting one of the largest Power GaN IP portfolios globally, promoting efficiency and cost-effectiveness in power electronics.
Transphorm, Inc. (NASDAQ: TGAN) has opened a new office in Shenzhen, China, reinforcing its commitment to the APAC power electronics market. This wholly foreign-owned enterprise (WFOE) aims to bolster local customer support, sales, and R&D for high-performance gallium nitride (GaN) products. Under the leadership of Kenny Yim, this facility will enhance engagement with regional customers and access local engineering talent. The GaN market is projected to reach $2 billion by 2027, indicating a growing demand for Transphorm's innovative solutions.
Transphorm, Inc. (NASDAQ: TGAN) reported its fiscal Q2 2023 results, revealing revenue of $3.7 million, down from $11.3 million in the same quarter last year, largely due to a one-time licensing revenue of $8.0 million in FY2022. However, excluding this, revenue improved by 11% year-over-year. Product revenue surged 38% year-over-year, driven by increased shipments and new design wins with Fortune 100 clients. Despite a net loss of $6.0 million, the company anticipates 20% sequential revenue growth in Q3, supported by a strong balance sheet and a focus on upcoming EV markets.
Transphorm, Inc. (NASDAQ: TGAN) has announced the appointment of six new executives, including Philip Zuk as Senior VP of Business Development and Marketing, and Sal Barlett as Senior VP of Operations. This strategic move aims to enhance the company's capabilities in response to growing demand for high voltage GaN power semiconductors. The new team brings a wealth of experience from leading industry roles, with a focus on driving efficiency and innovation in power conversion technologies.
Transphorm, Inc. (NASDAQ: TGAN) will host a conference call and webcast on November 9, 2022 at 5:00 p.m. ET to discuss its fiscal 2023 second quarter financial results. Known for its high-performance gallium nitride (GaN) power conversion products, Transphorm will provide insights into its operational performance during the call. Interested participants can register online, and a replay will be available following the live event. Transphorm is recognized for its extensive patent portfolio and advancements in power electronics.
Transphorm, Inc. (NASDAQ: TGAN) announced that President & COO Primit Parikh and CFO Cameron McAulay will present at the H.C. Wainwright 24th Annual Global Conference on September 12, 2022, and the Sequire Semiconductor Conference on September 15, 2022. The H.C. Wainwright conference presentation is available on demand from 7:00 a.m. ET. The Sequire conference presentation is scheduled for 2:30 p.m. ET. Transphorm specializes in high-reliability GaN power conversion products, boasting a significant IP portfolio.
Transphorm, Inc. (TGAN) has secured a contract from the Advanced Research Projects Agency-Energy (ARPA-E) as part of the CIRCUITS program. This project focuses on the development of GaN-based four-quadrant switches (FQSes) for innovative power conversion applications. Utilizing its advanced 650 V GaN technology, Transphorm aims to prototype these switches, which are expected to simplify designs by replacing multiple components with a single device. The project is anticipated to be completed within a year, highlighting the growing viability of GaN technology in power electronics.
Transphorm (NASDAQ: TGAN) reports Q1 2023 revenue of $5.2 million, a 60% increase year-over-year, marking the tenth consecutive quarter of product revenue growth. Product revenue reached a record $4.4 million, up 101% year-over-year. Despite strong growth, the company anticipates supply chain challenges impacting future revenue growth. Transphorm ended the quarter with $43.1 million in cash and equivalents. Operating expenses were $6.1 million, resulting in a GAAP net loss of ($5.4 million) or ($0.10) per share.